Kidney Disease: From Basic Research to Clinical Practice

Dear Colleagues,

Chronic kidney disease (CKD), with a reported global prevalence of 11–13%, is a great challenge for health systems due to its economic and social implications. As it is a chronic and irreversible disease, treatment is aimed at slowing its progression. Serum creatinine quantification is the method of choice for diagnosis and classification; however, this test has limited clinical sensitivity, which has led to the search for new markers for timely diagnosis and monitoring. From this perspective, the use of metabolomics and animal models has allowed the identification and study of new metabolites, which are future biomarker candidates in clinical practice. The objective of this Special Issue is to collect articles that analyze the metabolomic profile of CKD, both in experimental and in vivo models. Those currently being investigated and new candidate markers are used to further improve the determination of kidney function. All studies that analyze markers in CKD are welcome, including clinical trials on metabolomics, as well as studies on genetics, biochemical markers in polycystic kidney disease and novel therapeutic approaches.

Dr. Rafael Fernández Castillo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• kidney biomarkers
• dialysis
• CKD treatment
• chronic kidney disease
• polycystic kidney disease
• inflammation
• bone mineral disorders
• CKD anemia
• kidney physiopathology
• diabetic nephropathy